Many thanks to the co-authors and grateful for their collaboration and insight. 🙏🏽
Many thanks to the co-authors and grateful for their collaboration and insight. 🙏🏽
Delighted to share my first co-authored paper, now published in @PLOSMedicine
In our modelling study, we show that the projected population-level impact of new TB vaccines may depend on their efficacy in preventing infectious asymptomatic TB.
Read more: journals.plos.org/plosmedicine...
Our recent modelling study found that the estimated impact of new TB vaccines depends on the efficacy to prevent infectious asymptomatic TB. Read more in our paper out now in @plosmedicine.org!
journals.plos.org/plosmedicine...
In this modeling study, Allison Portnoy and colleagues investigate the potential impact of reduced international donor funding on the household economic burden of tuberculosis in low- and middle-income countries 🧪 #MedSky #TB
plos.io/4ryyBFX
1/📢 In our new publication, we estimate that in 2022, 134 million people worldwide had a recent Mycobacterium tuberculosis (Mtb) infection and were at high risk of progressing to TB disease. Read the full paper in PLOS Medicine (tinyurl.com/mtbinfection). #TBSky
Our framework that informed the @who.int TB & climate change policy brief out now in @lancetrespirmed.bsky.social, exploring the intersections and implications of climate change for the TB epidemic. Key message? TB should be considered a climate-sensitive disease
www.thelancet.com/journals/lan...